Your browser is no longer supported. Please, upgrade your browser.
AMPE Ampio Pharmaceuticals, Inc. weekly Stock Chart
AMPE [NYSE]
Ampio Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.32 Insider Own7.01% Shs Outstand109.52M Perf Week-3.25%
Market Cap54.48M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float99.07M Perf Month-1.05%
Income-20.70M PEG- EPS next Q- Inst Own16.80% Short Float14.33% Perf Quarter-71.41%
Sales- P/S- EPS this Y-123.00% Inst Trans47.91% Short Ratio6.10 Perf Half Y-80.72%
Book/sh-0.04 P/B- EPS next Y- ROA-162.40% Target Price14.00 Perf Year-9.89%
Cash/sh0.04 P/C11.59 EPS next 5Y- ROE176.30% 52W Range0.35 - 4.95 Perf YTD-87.78%
Dividend- P/FCF- EPS past 5Y-18.40% ROI- 52W High-89.95% Beta-0.17
Dividend %- Quick Ratio1.50 Sales past 5Y- Gross Margin- 52W Low41.67% ATR0.07
Employees17 Current Ratio1.50 Sales Q/Q- Oper. Margin- RSI (14)26.95 Volatility12.39% 12.97%
OptionableYes Debt/Eq- EPS Q/Q224.40% Profit Margin- Rel Volume0.52 Prev Close0.52
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume2.33M Price0.50
Recom- SMA20-14.05% SMA50-65.65% SMA200-78.46% Volume1,208,197 Change-4.35%
Mar-17-14Reiterated Aegis Capital Buy $15 → $16
Sep-25-12Initiated Aegis Capital Buy $11
Sep-19-18 06:29PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ampio Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - AMPE ACCESSWIRE
12:57PM  IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
Sep-18-18 07:13PM  Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Ampio Pharmaceuticals, Inc. Investors (AMPE) Business Wire -6.31%
04:33PM  IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
12:00PM  SHAREHOLDER ALERT: AMPE NVRO PZZA LOGM NLSN ZN GDS SKX PM QRTEA CRON: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Sep-17-18 04:35PM  Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Ampio Pharmaceuticals, Inc. Investors Business Wire
02:00PM  CLASS ACTION UPDATE for AMPE, NVRO, PZZA and LOGM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ampio Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - AMPE PR Newswire
Sep-16-18 01:15PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AMPE, NVRO, PZZA, PM, and QRTEA GlobeNewswire
Sep-14-18 07:29PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ampio Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline AMPE GlobeNewswire
04:30PM  SHAREHOLDER ALERT: AMPE NVRO LCI CBS PZZA FIZZ CRON PM QRTEA OPK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
10:38AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Ampio Pharmaceuticals, Inc. (AMPE) and Lead Plaintiff Deadline - October 24, 2018 ACCESSWIRE
Sep-13-18 12:34PM  CLASS ACTION UPDATE for PDD, AMPE and NVRO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire +15.56%
08:30AM  Ampio Reports Manuscript on the Mechanisms of Action (MOA) for Ampion accepted for Publication in "Clinical and Experimental Rheumatology" PR Newswire
Sep-12-18 06:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ampio Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - AMPE ACCESSWIRE
05:56PM  Robbins Arroyo LLP: Ampio Pharmaceuticals, Inc. (AMPE) Officers and Directors Breached Their Fiduciary Duties to Shareholders Business Wire
05:47PM  Lifshitz & Miller LLP Announces Investigation of Ampio Pharmaceuticals, CV Sciences, Inc., Facebook, Inc., Farmland Partners Inc., LogMeIn, Inc., Nevro Corporation, Sinclair Broadcast Group, Inc. and Tribune Media Company PR Newswire
02:26PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PDD, AMPE, LCI, CBS and PZZA GlobeNewswire
12:25PM  Pawar Law Group Announces a Securities Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. - AMPE ACCESSWIRE
Sep-10-18 08:21PM  Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Ampio Pharmaceuticals, Inc. (AMPE) and Encourages Investors to Contact the Firm GlobeNewswire
Sep-09-18 11:30AM  SHAREHOLDER ALERT: PDD AMPE NVRO PZZA ZN SBGI ACAD FIZZ TTPH FB: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Sep-08-18 01:00PM  AMPE LOSS NOTICE: Rosen Law Firm Files First Securities Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. AMPE GlobeNewswire
Sep-07-18 11:38PM  Pawar Law Group Announces a Securities Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. - AMPE ACCESSWIRE
07:12PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ampio Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline AMPE GlobeNewswire
03:34PM  AMPIO PHARMACEUTICALS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of Colorado against Ampio Pharmaceuticals, Inc. GlobeNewswire
Sep-05-18 12:43PM  CLASS ACTION UPDATE for AMPE, LCI and ZN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire -9.97%
10:15AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Ampio Pharmaceuticals, Inc. (AMPE) and Lead Plaintiff Deadline October 24, 2018 ACCESSWIRE
Sep-04-18 05:16PM  Dr. David Bar-Or retires as Chief Scientific Officer of Ampio Pharmaceuticals PR Newswire
05:08PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ACAD, RMTI, ORCL, AMPE and CBS GlobeNewswire
05:05PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ampio Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - AMPE ACCESSWIRE
03:58PM  Pawar Law Group Announces a Securities Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. - AMPE ACCESSWIRE
Sep-02-18 01:00PM  SHAREHOLDER ALERT: GLNCY FB HMNY GDS NLSN LOGM AMPE NVRO LCI CBS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Aug-31-18 04:54PM  Pomerantz Law Firm Announces the Filing of a Class Action against Ampio Pharmaceuticals, Inc. and Certain Officers  AMPE GlobeNewswire +5.31%
02:24PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LOGM, AMPE, LCI, CBS and PZZA GlobeNewswire
12:36PM  AMPE LOSS NOTICE: Rosen Law Firm Reminds Ampio Pharmaceuticals, Inc. Investors of Important Deadline in First Filed Case Commenced by Firm AMPE Business Wire
10:35AM  CLASS ACTION UPDATE for LOGM and AMPE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Aug-30-18 07:31PM  Robbins Arroyo LLP: Ampio Pharmaceuticals, Inc. (AMPE) Misled Shareholders According to a Recently Filed Class Action Business Wire -5.18%
05:17PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FB, SBGI, TSLA and AMPE GlobeNewswire
11:25AM  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. - AMPE ACCESSWIRE
10:00AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Ampio Pharmaceuticals, Inc. (AMPE) and Lead Plaintiff Deadline October 24, 2018 GlobeNewswire
Aug-29-18 05:26PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ampio Pharmaceuticals, Inc. - AMPE GlobeNewswire
Aug-28-18 03:35PM  SHAREHOLDER ALERT: RMTI TTPH NLSN TSLA PDD AMPE NVRO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
Aug-27-18 06:16PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. To Contact The Firm PR Newswire
04:23PM  CLASS ACTION UPDATE for AMPE and NVRO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:10AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Ampio Pharmaceuticals, Inc. (AMPE) and Lead Plaintiff Deadline - October 24, 2018 PR Newswire
09:00AM  Ampio Class Action: Bernstein Liebhard LLP Announces That a Securities Class Action Lawsuit Has Been Filed Against Ampio Pharmaceuticals, Inc. - AMPE GlobeNewswire
Aug-26-18 03:35PM  Ampio Class Action: Bernstein Liebhard LLP Announces That A Securities Class Action Lawsuit Has Been Filed Against Ampio Pharmaceuticals, Inc. - AMPE PR Newswire
Aug-25-18 11:03AM  EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. AMPE Business Wire
Aug-17-18 04:56PM  AMPIO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Ampio Pharmaceuticals, Inc. To Contact The Firm Business Wire
Aug-10-18 02:56PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ampio Pharmaceuticals, Inc. (AMPE) PR Newswire +16.13%
09:38AM  INVESTIGATION REMINDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ampio Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
Aug-09-18 06:30PM  INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ampio Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE -21.98%
05:35PM  AMPIO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Ampio Pharmaceuticals, Inc. To Contact The Firm PR Newswire
08:40AM  Ampio Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock and Warrants PR Newswire
08:00AM  Todays Research Reports on Stocks to Watch: Inovio Pharmaceuticals and Ampio Pharmaceuticals ACCESSWIRE
Aug-08-18 11:00PM  INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ampio Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire -78.71%
05:15PM  Ampio Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants PR Newswire
04:42PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Ampio Pharmaceuticals, Inc. GlobeNewswire
04:41PM  Investor Alert: Kaplan Fox Announces Investigation Of Ampio Pharmaceuticals, Inc. PR Newswire
02:46PM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Ampio Pharmaceuticals, Inc. AMPE Business Wire
12:15PM  Here's Why Ampio Pharmaceuticals Inc. Became a Penny Stock Today Motley Fool
12:10PM  AMPE Alert: Bernstein Liebhard LLP Announces Investigation Of Ampio Pharmaceuticals, Inc. - AMPE PR Newswire
09:34AM  Ampio's stock plunges below $1 threshold after FDA comments on clinical trial MarketWatch
08:00AM  Today's Research Reports on Trending Tickers: Ampio Pharmaceuticals and OPKO Health ACCESSWIRE
Aug-06-18 08:30AM  Ampio Hosting Conference Call Tuesday, August 7, 4:30 pm EDT to Update the Preparation of the Biologics License Application (BLA) for Ampion PR Newswire +13.62%
Aug-02-18 08:30AM  Ampio Pharmaceuticals, Inc. to Present at the 38th Annual Canaccord Genuity Growth Conference PR Newswire
Jul-23-18 08:10AM  Todays Research Reports on Stocks to Watch: Ampio Pharmaceuticals and Sorrento Therapeutics ACCESSWIRE +14.07%
Jul-12-18 12:45PM  Ampio provides a Link to New Publication on the Mechanism of Action for Ampion PR Newswire
Jun-29-18 07:25AM  Free Pre-Market Technical Recap on Sarepta Therapeutics and Three Additional Biotech Stocks ACCESSWIRE
Jun-27-18 08:30AM  Ampio Reports New Publication on the Mechanisms of Action for Ampion PR Newswire
Jun-25-18 08:05AM  Today's Research Reports on Stocks to Watch: bluebird and Ampio Pharmaceuticals ACCESSWIRE
Jun-05-18 08:30AM  Ampio Provides Scientific Update and Links to Peer Review Publications PR Newswire
May-29-18 08:30AM  Ampio Updates Regulatory and IP Activities PR Newswire -13.17%
May-23-18 07:00AM  Free Daily Technical Summary Reports on Amicus Therapeutics and Three Other Biotech Stocks ACCESSWIRE +6.16%
May-22-18 08:30AM  Ampio Updates Scientific presentations and publications on Ampion PR Newswire -10.21%
May-14-18 08:30AM  Ampio Provides Corporate Update PR Newswire
May-02-18 08:30AM  The Pivotal Trial Results on Ampion (AP-003-C) Was Accepted for Publication in a Peer-Reviewed Medical Journal PR Newswire
May-01-18 02:02PM  Who Really Owns Ampio Pharmaceuticals Inc (NYSEMKT:AMPE)? Simply Wall St.
Apr-13-18 03:51PM  How Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) Can Impact Your Portfolio Volatility Simply Wall St.
Apr-12-18 05:40PM  Ampio Updates Regulatory, Clinical and NYSE Activities PR Newswire
Apr-03-18 08:30AM  Ampio Updates Regulatory and Clinical Activities PR Newswire
Mar-29-18 08:25AM  New Research Coverage Highlights Apple Hospitality REIT, J.Jill, Benefitfocus, Ampio Pharmaceuticals, MFA Financial, and Del Frisco's Restaurant Group Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Mar-26-18 08:30AM  Evidence for Delay of Total Knee Replacement (TKR) for Patients with Severe Osteoarthritis of the Knee Receiving Three Intra-articular (IA) Ampion Injections PR Newswire +5.46%
Mar-15-18 05:00PM  Ampio Pharmaceuticals Provides Corporate Update Following Conference Call PR Newswire
Mar-06-18 05:25PM  Ampio Hosting Conference Call, Wednesday, March 7, 5:00 pm EST PR Newswire
Feb-16-18 03:21PM  Here's Why Ampio Pharmaceuticals Dropped as Much as 18.8% Today Motley Fool -14.45%
Feb-13-18 02:39PM  Is Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) Still A Cheap Healthcare Stock? Simply Wall St. +7.17%
Jan-26-18 07:30AM  Research Report Identifies Del Frisco's Restaurant Group, Capital Senior Living, Bazaarvoice, Macerich, Ampio Pharmaceuticals, and Diamondrock Hospitality with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Jan-22-18 03:00PM  Is Ampio Pharmaceuticals Incs (NYSEMKT:AMPE) CEO Salary Justified? Simply Wall St.
Jan-16-18 08:30AM  Ampio Update of J.P. Morgan Meeting Events and Disease Modification Discussions PR Newswire
Jan-15-18 02:51PM  What Does Ampio Pharmaceuticals Incs (NYSEMKT:AMPE) Ownership Structure Look Like? Simply Wall St.
Jan-08-18 08:30AM  Ampio Presentation at J.P. Morgan Healthcare Conference made available to all Shareholders PR Newswire
Jan-04-18 02:50PM  Did Ampio Pharmaceuticals Incs (NYSEMKT:AMPE) Recent Earnings Growth Beat The Trend? Simply Wall St. -16.61%
Jan-03-18 04:36PM  Here's Why Ampio Pharmaceuticals Sank as Much as 13.5% Today Motley Fool -13.51%
Dec-30-17 10:37AM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Dec-28-17 12:31PM  Why Ampio Pharmaceuticals Rose as Much as 15% Today Motley Fool +15.75%
Dec-14-17 11:29AM  Ampio Pharmaceuticals Inc (AMPE) Rallies as Knee Osteoarthritis Drug Findings Cheer SmarterAnalyst +33.14%
07:15AM  Ampio Pharmaceuticals Reports Positive Results for both Primary and Secondary Endpoints of Pivotal Phase 3 Trial of Ampion in Severe Osteoarthritis-of-the Knee (OAK) PR Newswire
Dec-04-17 08:10AM  Todays Research Reports on Stocks to Watch: Ampio Pharmaceuticals and Versartis ACCESSWIRE
Nov-30-17 08:00AM  Ampio Pharmaceuticals Announces Engagement of LaVoieHealthScience for Integrated Public and Investor Relations PR Newswire -24.86%
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process; and decreasing vascular permeability. Its product pipeline includes Ampion, an intra-articular injection for the treatment of osteoarthritis of the knee; and Optina, an oral agent for the treatment of diabetic macular edema. Ampio Pharmaceuticals, Inc. is headquartered in Englewood, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COELHO PHILIP HDirectorSep 27Buy0.6310,0006,270104,727Sep 28 05:15 PM
COELHO PHILIP HDirectorSep 22Buy0.603,0001,80094,727Sep 22 06:56 PM
COELHO PHILIP HDirectorSep 20Buy0.591,00059291,727Sep 22 06:56 PM